BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32935219)

  • 1. Pharmacogenetic determinants of thiopurines in an Indian cohort.
    Naushad SM; Janaki Ramaiah M; Kutala VK; Hussain T; Alrokayan SA
    Pharmacol Rep; 2021 Feb; 73(1):278-287. PubMed ID: 32935219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients.
    Shah SA; Paradkar M; Desai D; Ashavaid TF
    J Gastroenterol Hepatol; 2017 Mar; 32(3):620-624. PubMed ID: 27416873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
    Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
    Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
    Kakuta Y; Kinouchi Y; Shimosegawa T
    J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
    Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
    BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
    Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
    BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
    Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B
    Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity.
    Shah SAV; Paradkar MU; Desai DC; Ashavaid TF
    Drug Metab Pers Ther; 2018 Mar; 33(1):57-60. PubMed ID: 29470173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
    Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
    Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
    J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India.
    Banerjee R; Ravikanth VV; Pal P; Bale G; Avanthi US; Goren I; Girish BG; Mitnala S; Reddy DN
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1683-1694. PubMed ID: 33111378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of
    Kojima Y; Hirotsu Y; Omata W; Sugimori M; Takaoka S; Ashizawa H; Nakagomi K; Yoshimura D; Hosoda K; Suzuki Y; Mochizuki H; Omata M
    World J Gastroenterol; 2018 Jan; 24(4):511-518. PubMed ID: 29398872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
    Moriyama T; Yang W; Smith C; Pui CH; Evans WE; Relling MV; Bhatia S; Yang JJ
    Pharmacogenet Genomics; 2022 Feb; 32(2):60-66. PubMed ID: 34412101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico.
    Texis T; Guzmán-Cruz C; Rodríguez-Dorantes M; Sánchez-García S; Mino-León D; Gonzalez-Covarrubias V
    Pharmacol Rep; 2022 Feb; 74(1):257-262. PubMed ID: 34091879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of
    Nghia H; Than HH; Dong CV; Oanh TTK; Truc VTT; Ngan CTT; Ngon HT; Binh NT; Dung PC; Anh Vu H; Xinh PT
    Pediatr Hematol Oncol; 2022 Sep; 39(6):561-570. PubMed ID: 35156873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis.
    Jena A; Jha DK; Kumar-M P; Kasudhan KS; Kumar A; Sarwal D; Mishra S; Singh AK; Bhatia P; Patil A; Sharma V
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):491-501. PubMed ID: 33682590
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
    Khera S; Trehan A; Bhatia P; Singh M; Bansal D; Varma N
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):341-348. PubMed ID: 30474703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT.
    Kim H; You S; Park Y; Choi JY; Ma Y; Hong KT; Koh KN; Yun S; Lee KH; Shin HY; Lee S; Yoo KH; Im HJ; Kang HJ; Kim JH
    Sci Rep; 2021 May; 11(1):9676. PubMed ID: 33958640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease.
    Zhu X; Wang XD; Chao K; Zhi M; Zheng H; Ruan HL; Xin S; Ding N; Hu PJ; Huang M; Gao X
    Aliment Pharmacol Ther; 2016 Nov; 44(9):967-975. PubMed ID: 27604507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.